NCT00746811View on ClinicalTrials.gov

Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
Primary Hypercholesterolemia
Interventions
DRUG

P-OM3

4 grams/day - 4 one gram capsules

DRUG

Placebo

4 grams/day - 4 one gram capsules

Trial Locations (1)

60101

Provident Clinical Research, Addison

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Provident Clinical Research

OTHER

NCT00746811 - Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia | Biotech Hunter | Biotech Hunter